These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8190667)

  • 1. Effect of HIV treatment on cognition, behavior, and emotion.
    Katz MH
    Psychiatr Clin North Am; 1994 Mar; 17(1):227-30. PubMed ID: 8190667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of HIV disease in 1993/1994.
    Fischl MA
    AIDS Clin Rev; 1993-1994; ():167-87. PubMed ID: 8217898
    [No Abstract]   [Full Text] [Related]  

  • 5. Back to the nukes.
    Smart T
    GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of didanosine in the management of HIV-1 infection.
    Gazzard BG; Moyle GJ
    Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
    Molina JM; Chêne G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM
    J Infect Dis; 1999 Aug; 180(2):351-8. PubMed ID: 10395849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A short-term trial of Didanosine, stavudine, and nevirapine combination therapy for human immunodeficiency virus infection].
    Zheng YH; Yang X; Chang WH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):390. PubMed ID: 14653126
    [No Abstract]   [Full Text] [Related]  

  • 11. D4T nucleoside combinations for HIV.
    Pollard RB
    Antiviral Res; 1996 Jan; 29(1):101-4. PubMed ID: 8721558
    [No Abstract]   [Full Text] [Related]  

  • 12. [AIDS studies with didanosine and stavudine].
    Dtsch Med Wochenschr; 1996 May; 121(22):A30. PubMed ID: 8646981
    [No Abstract]   [Full Text] [Related]  

  • 13. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
    Rutschmann OT; Opravil M; Iten A; Malinverni R; Vernazza PL; Bucher H; Bernasconi E; Perrin LH; Yerly S; Hirschel B
    Antivir Ther; 1998; 3 Suppl 4():65-7. PubMed ID: 10723515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy for adults and children.
    AIDS Inst Newsl; 1995 Jun; ():1-19. PubMed ID: 11367409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
    Lewis W
    Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ddI and d4T plus protease inhibitors.
    GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stavudine plus a non-thymidine nucleoside reverse transcriptase inhibitor as a backbone for highly active antiretroviral therapy.
    Clumeck N
    Antivir Ther; 1998; 3 Suppl 4():39-43. PubMed ID: 10723508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
    Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
    Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team.
    Raffi F; Reliquet V; Francois C; Garre M; Hascoet C; Allavena C; Arvieux C; Breux JP; Perre P; Rozenbaum W; Auger S
    Antivir Ther; 1998; 3 Suppl 4():57-60. PubMed ID: 10723512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.